Sort   by:  
 Page size 
UnknownRNA-Modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors.
Not available
S-EPMC6453546 | biostudies-literature
UnknownImmune Escape After Adoptive T-cell Therapy for Malignant Gliomas.
Not available
S-EPMC9371689 | biostudies-literature
UnknownIMMU-27. IMMUNE CHECKPOINT BLOCKADE OF EX VIVO EXPANDED T CELLS FOR USE IN ADOPTIVE CELLULAR THERAPY (ACT) FOR GLIOBLASTOMA
Not available
S-EPMC6846700 | biostudies-literature
UnknownCross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma.
Not available
S-EPMC6095818 | biostudies-literature
UnknownMassive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy.
Not available
S-EPMC6881165 | biostudies-literature
UnknownClinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review.
Not available
S-EPMC9197870 | biostudies-literature
UnknownTMIC-29. REPROGRAMMING BONE MARROW OF TUMOR-BEARING HOSTS FOR GLIOMA IMMUNOTHERAPY
Not available
S-EPMC6216412 | biostudies-literature
UnknownLin-CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade.
Not available
S-EPMC6192988 | biostudies-literature
UnknownEffect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial.
Not available
S-EPMC6379110 | biostudies-literature
UnknownShp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity.
Not available
S-EPMC7550718 | biostudies-literature
Sort   by:  
 Page size